As such, the type I IFNGS expression observed in patients with SLE may also reflect type II and III interferon activity, and assessment of IFN cytokine levels in future studies could help to pinpoint the precise contributing interferon mediators. This evidence concerns the gene SGCG and systemic lupus erythematosus.